Exam 2- 6/7 Flashcards
(49 cards)
some known vesicants
anthracyclines (rubicines, vinca alkaloids, etc
anthracylines MOA of tissue destruction
DNA binding
- binds with DNA of surrounding cells
- most toxic
vinca alkaloids MOA of tissue destruction
non_DNA binding
- cause immediate cell destruction. have a shorter duration
patient-related risk factors for extravasation
multiple venipunctures, very young or very old, heavily sedated patients, parathesias, inability to communicate
prevention strategies
central venous catheters, flexible catheters, repeat punctures should be proximal to prior, admin IV push through free flowing IV if given peripherally, check for frequent blood return during infusion, site is important, patient education
clinical presentation of extravasation
local pain and burning, swelling and erythema, lack of blood return, skin ulceration and skin necrosis
sodium bicarb
increases pH, increases tissue uptake of anthracyclines
glucocorticoids
- little to no inflammatory response has been found in tissues with extravasation
anthracycline extravasation treatment
apply cold
- DMSO
- dexrazoxane
(one or the other)
mechlorethamine extravasation treatment
appy cold
- 1/6M solution of sodium thiosulfate
vinca alkaloids extravasation treatment
- apply HEAT
- hyaluronidase: breaks down SQ tissue to increase clearing
tumors commonly associated with hypercalcemia
breast, multiple myeloma, lung, squamous cell cancer of head, neck, esophagus & female genital traction, NHL, leukemia, renal, cervical, colon
corrected calcium formular
- correct when albumin less than 3.5
Ca+0.8 (4-albumin)
osteolytic HCM
metastatic tumor cells release stuff that stimulates osteoclasts, osteoclasts release growth factors that stimular tumor growth
SXS HCM GI:
constipation, N/V, anorexia
SXS HCM renal:
polyuria, polydipsia, dehydration, decreased GFR
SXS HCM neurological
lethargy and confusion, irritability, fatigue, muscle weakness, seizures, stupor, coma
SXS HCM cardiac
shortened QT interval, widened T wave, heart block, asystole, arrhythmias
3 basic interventions for HCM
- treat underlying malignancy
- DC drugs that increase serum Ca or decrease renal blood flow
- encourage ambulation
mild HCM treatment
Ca less than 12 and asymptomatic
- oral fluids
moderate HCM treatment
Ca 12-14 and symptomatic
- hydrate + lasix
severe HCM treatment
Ca 14-16 regardless of symptoms
- treatment+ calcitonin
HCM hydration
- NA 200-500ml/hr
- furosemide
- reduces Ca by 1.5-2.5; onset 12-24 hours
HCM treatment
- bisphosphonates: zoledronic acid (better), pamidronate
- reduces ca by 2-4; onset 48 hours